← All companies ← JLL Manual JNPR → ← JAZZ Pharmaceuticals KMDA →
JNJ, Johnson & Johnson
Johnson & Johnson researches, makes and sells a broad range of healthcare products worldwide. One half of the business, Innovative Medicine, discovers and sells patent-protected prescription drugs; the other half, MedTech, makes the devices and instruments that surgeons and hospitals use. The customers are patients and doctors, but the bills are paid by the hospitals, insurers and governments standing behind them.
The Company's primary focus is products related to human health and well-being.
Segments of business The Company is organized into two business segments: Innovative Medicine and MedTech.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What it is
- Revenue is Innovative Medicine (64%) and MedTech (36%).
- Situation
- Serial acquirer. Goodwill and acquired intangibles are 50% of assets, with meaningful acquisition spending in 5 of the record's 8 years; much of what this business is was bought, at prices the record carries.
- What moves the needle
- A patented drug is a license to charge a high price — until the patent expires and generics take the sales. So the test for the medicine half is whether the lab and the deal-making can replace expiring drugs as fast as the patents run out; weigh the research spend against the calendar of cliffs. For the device half, the test is switching cost: whether a tool, once trained into a surgeon's hands and built into a hospital's routine, is hard to displace. Against both stand the drug-pricing rules set by the governments that pay and the long shadow of product litigation the filing keeps in plain view — and the margins, returns and debt that show how well the franchise holds are in the record below.
- Is it a good business?
- Return on capital has run high across the record (median 22%, above 15% in 7 of 8 years). Owner earnings agree: roughly 23% of revenue reaches owners as cash, consistently. Whether these returns reflect real pricing power or an accounting artifact is the judgment the 10-K is for.
Drafted from the company's filings and reviewed by hand; every number is shown in full in the sections below.
Where the money comes from
read the 10-K →Innovative Medicine is 64% of revenue, with MedTech the other meaningful segment at 36%.
- Innovative Medicine64%$60.4B
- MedTech36%$33.8B
From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.
The record
Ten years of arithmetic, read across the cycle.
The record, 2017–2025
realized figures from each filing · older years to the left| 2017’17 | 2018’18 | 2019’19 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMMar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| $76.5B | $81.6B | $82.1B | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B | $96.4B | RevenueRevenue |
| 67% | 67% | 66% | 66% | 70% | 69% | 69% | 68% | 68% | Gross marginGross mgn |
| 28% | 28% | 27% | 27% | 26% | 25% | 26% | 25% | 26% | SG&A / revenueSG&A/rev |
| 14% | 13% | 14% | 15% | 0% | 1% | 2% | 0% | 0% | R&D / revenueR&D/rev |
| $18.6B | $19.0B | $17.6B | $16.7B | $22.4B | $37.2B | $17.4B | $33.6B | $21.8B | Operating incomeOp. inc. |
| 24.3% | 23.3% | 21.5% | 20.2% | 28.5% | 43.6% | 19.6% | 35.6% | 22.6% | Operating marginOp. mgn |
| $1.3B | $15.3B | $15.1B | $14.7B | $20.9B | $35.2B | $14.1B | $26.8B | $21.0B | Net incomeNet inc. |
| — | 15% | 13% | 11% | 6% | 5% | 16% | 18% | 16% | Effective tax rateTax rate |
| Cash flow & returns | |||||||||
| $21.1B | $22.2B | $23.4B | $23.5B | $23.4B | $22.8B | $24.3B | $24.5B | $22.9B | Operating cash flowOp. cash |
| $5.6B | $6.9B | $7.0B | $7.2B | $7.4B | $7.5B | $7.3B | $7.5B | $7.7B | DepreciationDeprec. |
| $13.2B | ($1.0B) | $311M | $586M | ($6.0B) | ($21.0B) | $1.7B | ($11.1B) | ($7.3B) | Working capital & otherWC & other |
| $3.3B | $3.7B | $3.5B | $3.3B | $3.7B | $4.5B | $4.4B | $4.8B | $5.1B | CapexCapex |
| 4.3% | 4.5% | 4.3% | 4.1% | 4.6% | 5.3% | 5.0% | 5.1% | 5.3% | Capex / revenueCapex/rev |
| $17.8B | $18.5B | $19.9B | $20.2B | $19.8B | $18.2B | $19.8B | $19.7B | $17.8B | Owner earningsOwner earn. |
| 23.3% | 22.7% | 24.3% | 24.4% | 25.1% | 21.4% | 22.3% | 20.9% | 18.5% | Owner earnings marginOE mgn |
| $17.8B | $18.5B | $19.9B | $20.2B | $19.8B | $18.2B | $19.8B | $19.7B | $17.8B | Free cash flowFCF |
| 23.3% | 22.7% | 24.3% | 24.4% | 25.1% | 21.4% | 22.3% | 20.9% | 18.5% | Free cash flow marginFCF mgn |
| $35.2B | $899M | $5.8B | $7.3B | $60M | $0 | $15.1B | $17.5B | $17.5B | AcquisitionsAcquis. |
| $6.4B | $5.9B | $6.7B | $3.2B | $3.5B | $5.1B | $2.4B | $6.0B | — | BuybacksBuybacks |
| 13% | 22% | 22% | 18% | 23% | 43% | 18% | 27% | 19% | ROICROIC |
| 2% | 26% | 25% | 23% | 28% | 46% | 20% | 33% | 26% | Return on equityROE |
| 2% | 26% | 25% | 23% | 28% | 46% | 20% | 33% | 26% | Retained to equityRetained/eq |
| Balance sheet | |||||||||
| $19.4B | $19.7B | $19.3B | $25.2B | $31.6B | $22.9B | $24.5B | $20.1B | $22.1B | Cash & investmentsCash+inv |
| $13.5B | $14.1B | $14.5B | $13.6B | $15.3B | $14.9B | $14.8B | $17.2B | $17.7B | ReceivablesReceiv. |
| $8.8B | $8.6B | $9.0B | $9.3B | $10.4B | $11.2B | $12.4B | $14.2B | $14.6B | InventoryInvent. |
| $7.3B | $7.5B | $8.5B | $9.5B | $11.1B | $9.6B | $10.3B | $12.0B | $10.5B | Accounts payablePayables |
| $14.9B | $15.2B | $15.0B | $13.4B | $14.6B | $16.4B | $17.0B | $19.4B | $21.8B | Operating working capitalOper. WC |
| $43.1B | $46.0B | $45.3B | $51.2B | $61.0B | $53.5B | $55.9B | $55.6B | $59.2B | Current assetsCur. assets |
| $30.5B | $31.2B | $36.0B | $42.5B | $45.2B | $46.3B | $50.3B | $54.1B | $57.7B | Current liabilitiesCur. liab. |
| 1.4× | 1.5× | 1.3× | 1.2× | 1.3× | 1.2× | 1.1× | 1.0× | 1.0× | Current ratioCurr. ratio |
| $31.9B | $30.5B | $33.6B | $36.4B | $25.4B | $36.6B | $44.2B | $48.8B | $48.6B | GoodwillGoodwill |
| $157.3B | $153.0B | $157.7B | $174.9B | $182.0B | $167.6B | $180.1B | $199.2B | $200.9B | Total assetsAssets |
| $32.2B | $30.3B | $27.7B | $34.4B | $32.1B | $27.4B | $32.4B | $41.4B | $39.5B | Total debtDebt |
| $12.7B | $10.6B | $8.4B | $9.2B | $508M | $4.4B | $7.9B | $21.3B | $17.5B | Net debt / (cash)Net debt |
| 19.9× | 18.9× | 55.5× | 83.1× | 122.6× | 134.7× | 23.1× | 34.6× | 20.9× | Interest coverageInt. cov. |
| $60.2B | $59.8B | $59.5B | $63.3B | $74.0B | $76.8B | $71.5B | $81.5B | $81.2B | Shareholders’ equityEquity |
| 1.3% | 1.2% | 1.2% | 1.2% | 1.4% | 1.4% | 1.3% | 1.4% | 1.4% | Stock comp / revenueSBC/rev |
| Per share | |||||||||
| 2.75B | 2.73B | 2.68B | 2.67B | 2.67B | 2.56B | 2.43B | 2.43B | 2.45B | Shares out (diluted)Shares |
| $27.85 | $29.90 | $30.57 | $30.92 | $29.45 | $33.26 | $36.56 | $38.77 | $39.41 | Revenue / shareRev/sh |
| $0.47 | $5.61 | $5.63 | $5.51 | $7.81 | $13.73 | $5.79 | $11.03 | $8.60 | EPS (diluted)EPS |
| $6.48 | $6.79 | $7.42 | $7.56 | $7.39 | $7.13 | $8.17 | $8.11 | $7.27 | Owner earnings / shareOE/sh |
| $6.48 | $6.79 | $7.42 | $7.56 | $7.39 | $7.13 | $8.17 | $8.11 | $7.27 | Free cash flow / shareFCF/sh |
| $1.19 | $1.34 | $1.30 | $1.25 | $1.37 | $1.77 | $1.82 | $1.99 | $2.08 | Cap. spending / shareCapex/sh |
| $21.91 | $21.90 | $22.16 | $23.69 | $27.68 | $30.00 | $29.43 | $33.57 | $33.20 | Book value / shareBVPS |
| 8-yr | 5-yr | |
|---|---|---|
| Revenue / share | +4.2%/yr | +5.8%/yr (4-yr) |
| Owner earnings / share | +2.9%/yr | +1.8%/yr (4-yr) |
| EPS | +48.2%/yr | +19.0%/yr (4-yr) |
| Capital spending / share | +6.6%/yr | +12.2%/yr (4-yr) |
| Book value / share | +5.5%/yr | +9.1%/yr (4-yr) |
The record, charted
FY2017–2025Each measure over its full record; the current point and the worst year marked.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cashEach year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business reported $26.8B of profit but $19.7B of owner earnings: $7.1B less than the profit line, taken out by capital spending and the timing of cash.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | $26.8B | $14.1B | $35.2B | $20.9B | $14.7B |
| Depreciation & amortizationnon-cash charge added back | +$7.5B | +$7.3B | +$7.5B | +$7.4B | +$7.2B |
| Stock-based compensationreal costnon-cash, but a real cost | +$1.4B | +$1.2B | +$1.2B | +$1.1B | +$1.0B |
| Working capital & othertiming of cash in and out, other non-cash items | −$11.1B | +$1.7B | −$21.0B | −$6.0B | +$586M |
| Cash from operations | $24.5B | $24.3B | $22.8B | $23.4B | $23.5B |
| Capital expenditurecash put back in to keep running and to grow | −$4.8B | −$4.4B | −$4.5B | −$3.7B | −$3.3B |
| Owner earnings | $19.7B | $19.8B | $18.2B | $19.8B | $20.2B |
| Owner-earnings marginowner earnings ÷ revenue | 21% | 22% | 21% | 25% | 24% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $1.4B), owner earnings is nearer $18.3B.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? 22.2×ComfortableOperating income $21.6B ÷ interest expense $971M
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- How heavy is the debt, net of cash? $21.3B · 1.0× operating profitModest net debtCash $19.7B + ST investments $393M − debt $41.4B
What this means
Netting $20.1B of cash and short-term investments against $41.4B of debt leaves $21.3B owed, about 1.0× a year's operating profit (1.9× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 67 + DIO 171 − DPO 145 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- High through the cycle8-yr median, range 13%–43%; 17% latest = NOPAT $17.8B ÷ invested capital $103.3BIndustry peers: median 19%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 8 years (it ran 17% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- High through the cycle8-yr median margin, range 21%–25%; latest $19.7B = operating cash $24.5B − maintenance capex $4.8BIndustry peers: median 21%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 21% of revenue this year, a 23% median across 8 years. Treating stock comp as the real expense it is (less $1.4B of SBC) leaves $18.3B.
- Mostly cash-backedCash from ops $24.5B ÷ net income $26.8B
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Reinvests most of itDividends + buybacks $6.0B ÷ Owner Earnings $19.7B
What this means
Of $19.7B Owner Earnings, $6.0B (30%) went back to shareholders, $0 dividends, $6.0B buybacks. Net of $1.4B stock comp, the real buyback was about $4.6B. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 0.64×HarvestingCapex $4.8B ÷ depreciation $7.5B
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 3 of 6 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size PassRevenue ≥ $2B · $94.2B
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity MissCurrent ratio ≥ 2× · 1.03×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $41.4B vs $1.5B WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability PassA profit every year (8-yr record) · no losses
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record MissUninterrupted dividends · none paid
What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
- Earnings growth PassEarnings +33% over the record · +140%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $10.53/share (latest year $11.13), the averaged base the calculator's gate runs on, and book value is $33.87/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2017–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 8 of 8
What this means
Never lost money over the record, the earnings stability Graham insisted on.
- Return on capital ≥ 15% 7 of 8 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 23% → 33% (3-yr avg ends)
In the filing’s words The filing ties gains to its own pricing, but names price competition too — pricing power that is real yet contested, not unopposed. The margin shows who is winning.
What this means
Through the cycle the operating margin widened — about 23% early to 33% lately, median 23% — pricing power intact or improving.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Owner earnings growth +1%/yr
What this means
Owner earnings grew about 1% a year over the record.
- Worst year 2024 · 19.6% op. margin
What this means
Stayed profitable even in its hardest year, the resilience that survives recessions.
- Share count −1.5%/yr
What this means
The share count is shrinking, buybacks are quietly growing your slice of the business.
- How management talks about it Promotional
What this means
Results have held roughly flat while the filing leans on a promoter’s vocabulary — watch whether the words are doing work the numbers are not.
Does AI threaten the moat?
Low contestabilityThe moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.
Its FY2025 10-K names artificial intelligence as a competitive threat.
“AI technology is continuously evolving, and the AI technologies we develop and adopt may become obsolete earlier than planned.”
AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Mar 29, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$22.1B
- Receivables$17.7B
- Inventory$14.6B
- Other current assets$4.8B
- Debt due within a year$2.0B
- Accounts payable$10.5B
- Other current liabilities$45.3B
From the company's latest filing.
Debt maturity
the debt note, SEC EDGAR →Not how much it owes, but when it falls due, and against what. The ladder the company files, beside cash on hand and a year's owner earnings.
Bars scaled to the largest single year; “later” is everything due after 2030, shown apart since it dwarfs the years.
Against what the business has and earns
Cash on hand as of Mar 29, 2026 plus a year’s owner earnings comes to $41.7B against the $2.0B due in the twelve months after the Dec 28, 2025 schedule: 21 times it.
Maturity schedule extracted from the company’s Dec 28, 2025 annual report and reconciled to the total the table states.
How the cash was used, 2017–2025
Over the record, the business generated $185.2B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.
- Reinvested$31.2B · 17%
- Buybacks$39.1B · 21%
- Retained (debt / cash)$114.9B · 62%
- Returned to owners$39.1B
25% of the owner earnings the business produced over the span, $0 as dividends and $39.1B as buybacks.
- Average price paid for buybacks—
Buybacks ran $39.1B over the span, but the filings don't tag the share count needed to deduce the average price paid.
- Net change in share count−10.9%
The diluted count fell from 2745M to 2445M, so the buybacks outran the stock issued to staff.
- Dividend record—
No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.
- Return on what it retained0%
Of the earnings it kept rather than paid out ($104.2B over the span), annual owner earnings (first three years vs last three) grew $521M, so each retained $1 added about 0.00 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Acquisitions & goodwill
from the balance sheet & the 8-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 8-year record, from the company's own filings.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2022 | A. Gorsky | $26.7M | $39.4M | $19.8B |
| 2023 | — | $28.4M | $13.8M | $18.2B |
| 2024 | J. Duato | $24.3M | $17.0M | $19.8B |
| 2025 | — | $32.8M | $68.3M | $19.7B |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years. A dash under the name means the filing tags the figure without naming the officer.
- Insider ownership<1%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
- CEO pay ratio360:1
What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.
- Stock-based compensation$1.4B
The slice of the business handed to employees in shares this year, 1% of revenue, equal to 6% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
Inverting the record
Invert: instead of why Johnson & Johnson is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2017–2025.
1 of the 6 tests turned up something to look into; the other 5 came back clean.
- Look hereAre "one-time" charges a yearly habit?8 of 8 years
Management took an impairment or write-down in 8 of the last 8 years, $6.3B in all. A charge taken almost every year is not one-time; it is the business — past deals coming due, and an admission the assets were worth less than what was paid. Munger's rule: when the "one-time" keeps happening, it is the business. Read it beside the goodwill the company still carries.
- Is it less profitable than it was?
- Did the share count rise anyway?
- Did debt outgrow the business?
- Did reported profit become cash?
- Did receivables and inventory outpace sales?
Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.
What an owner would ask, FY2025
read the 10-K →- Which reported numbers are a judgment call?Management names Revenue recognition, Pension & retirement, Income taxes, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Pharmaceuticals
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| JNJJohnson & Johnson | $94.2B | 67% | 23.8% | 22% | 23% |
| PGProcter & Gamble Co. | $84.3B | 50% | 22.1% | 21% | 18% |
| LLYEli Lilly and Company | $65.2B | 78% | 24.0% | 27% | 20% |
| MRKMerck & Company Inc. Common Stock (new) | $65.0B | 70% | 25.9% | 19% | 21% |
| PFEPfizer Inc. | $62.6B | 75% | 26.1% | 11% | 28% |
| ABBVAbbVie Inc. | $61.2B | 70% | 28.0% | 21% | 38% |
| BMYBristol-Myers Squibb Company | $48.2B | 72% | 18.9% | 12% | 28% |
| ABTAbbott Laboratories | $44.3B | 56% | 15.8% | 11% | 17% |
| Group median | — | 70% | 23.9% | 20% | 22% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Johnson & Johnson has delivered.
Through the cycle, Johnson & Johnson earns about $21.6B on its 23.0% median owner-earnings margin. This year’s 20.9% margin runs in line with that. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $17.8B on 2407M shares outstanding, per the 10-Q cover, as of 2026-04-17; net debt $17.5B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← JLL its page in the Manual JNPR →
Industry order: ← JAZZ the Pharmaceuticals chapter KMDA →